Mukka Proteins approved issuing up to 2 crore convertible warrants to non-promoters. The move aims to raise ₹47 crore for expansion and working capital. This could lead to equity dilution for existing shareholders.

Mukka Proteins to Raise ₹47 Crore via Convertible Warrants

Mukka Proteins Limited will issue up to 2,00,00,000 convertible warrants to non-promoter investors for ₹47 crore.

Reader Takeaway: Funding growth via warrants secures capital without immediate debt; watch for equity dilution.

What just happened

The Board of Directors of Mukka Proteins has approved the issuance of up to 2 crore convertible warrants to non-promoter investors on a preferential basis. The issue size is ₹47 crore (₹4,700 lakh) at a price of ₹23.50 per warrant.

Each warrant allows the holder to subscribe to one equity share of face value ₹1 at a premium of ₹22.50. Investors will pay 25% of the issue price upfront, with the remaining 75% due upon conversion within 18 months. Failure to convert within this period will result in forfeiture of the upfront payment.

Why this matters

This move provides Mukka Proteins with significant capital for business expansion, working capital requirements, and new growth initiatives. Management views this as an efficient way to augment long-term financial resources without incurring immediate interest costs associated with debt.

The backstory

Mukka Proteins is a manufacturer of animal feed. The company recently went public with its IPO in March 2024.

What changes now

Upon full conversion of these warrants, the company's paid-up capital is expected to increase from ₹30 crore to ₹32 crore. This represents a potential equity dilution for existing shareholders.

Risks to watch

Existing shareholders need to be aware of the potential equity dilution upon full conversion of the warrants. Additionally, there is an execution risk regarding whether the allottees will exercise their conversion options within the 18-month timeframe.

Peer comparison

(No peer comparison data available in the filing)

Context metrics (time-bound)

The floor price for the preferential issue was set in accordance with SEBI ICDR Regulations, considering the 90-day VWAP of ₹23.17 and the 10-day VWAP of ₹22.26. The issue price of ₹23.50 per warrant is higher than the floor price.

What to track next

Investors should monitor the postal ballot process for formal approval of this warrant issuance and track subsequent updates on the conversion of these warrants into equity shares.